CHRONIC GRAFT VERSUS HOST DISEASE IN EYE

CHRONIC GRAFT VERSUS HOST DISEASE IN EYE was reported 203 times

CHRONIC GRAFT VERSUS HOST DISEASE IN EYE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] 5 0.0015
1 Calcineurin Inhibitor Immunosuppressant [EPC] 78 0.0006
2 CD38-directed Cytolytic Antibody [EPC] 3 0.0005
3 Guanylate Cyclase-C Agonist [EPC] 1 0.0005
4 CCR5 Co-receptor Antagonist [EPC] 1 0.0004
5 CD22-directed Immunoconjugate [EPC] 1 0.0003
6 Janus Kinase Inhibitor [EPC] 42 0.0003
7 Human alpha-1 Proteinase Inhibitor [EPC] 1 0.0002
8 Alkylating Drug [EPC] 56 0.0002
9 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 4 0.0002
10 Thymic Stromal Lymphopoietin Blocker [EPC] 1 0.0001
11 Sphingosine 1-phosphate Receptor Modulator [EPC] 2 0.0001
12 Echinocandin Antifungal [EPC] 1 0.0001
13 Kinase Inhibitor [EPC] 66 0.0001
14 BCL-2 Inhibitor [EPC] 7 0.0001
15 Folate Analog Metabolic Inhibitor [EPC] 48 0.0001
16 Azole Antifungal [EPC] 17 0.0001
17 Purine Antimetabolite [EPC] 10 0.0001
18 Provitamin D2 Compound [EPC] 3 0.0001
19 CD19-directed Chimeric Antigen Receptor [EPC] 1 0.0001
20 Nucleoside Metabolic Inhibitor [EPC] 24 0.0001
21 Corticosteroid [EPC] 96 0.0001
22 RNA Synthetase Inhibitor Antibacterial [EPC] 1 0.0001
23 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 7 0.0001
24 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 7 0.0001
25 Integrin Receptor Antagonist [EPC] 5 0.0001
26 CD20-directed Cytolytic Antibody [EPC] 18 0.0001
27 Human Immunoglobulin G [EPC] 1 0.0000
28 Antimetabolite Immunosuppressant [EPC] 1 0.0000
29 Bile Acid [EPC] 1 0.0000
30 Topoisomerase Inhibitor [EPC] 3 0.0000
31 Histamine-1 Receptor Antagonist [EPC] 3 0.0000
32 Leukocyte Growth Factor [EPC] 5 0.0000
33 Peroxisome Proliferator Receptor alpha Agonist [EPC] 2 0.0000
34 gamma-Aminobutyric Acid-ergic Agonist [EPC] 3 0.0000
35 Rifamycin Antibacterial [EPC] 1 0.0000
36 Fluoroquinolone Antibacterial [EPC] 3 0.0000
37 Histamine-2 Receptor Antagonist [EPC] 3 0.0000
38 Selective T Cell Costimulation Modulator [EPC] 3 0.0000
39 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 2 0.0000
40 Complement Inhibitor [EPC] 1 0.0000
41 Catecholamine [EPC] 1 0.0000
42 Nucleoside Analog Antiviral [EPC] 1 0.0000
43 Dietary Cholesterol Absorption Inhibitor [EPC] 1 0.0000
44 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
45 Osmotic Laxative [EPC] 3 0.0000
46 Aminosalicylate [EPC] 1 0.0000
47 5-alpha Reductase Inhibitor [EPC] 1 0.0000
48 Thalidomide Analog [EPC] 5 0.0000
49 Retinoid [EPC] 2 0.0000
50 Phosphodiesterase 5 Inhibitor [EPC] 1 0.0000
51 Factor Xa Inhibitor [EPC] 2 0.0000
52 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
53 Platelet Aggregation Inhibitor [EPC] 4 0.0000
54 Vitamin B12 [EPC] 2 0.0000
55 Expectorant [EPC] 1 0.0000
56 Loop Diuretic [EPC] 2 0.0000
57 Opioid Agonist [EPC] 1 0.0000
58 Platinum-based Drug [EPC] 1 0.0000
59 Proton Pump Inhibitor [EPC] 2 0.0000
60 Vitamin D [EPC] 1 0.0000
61 Nonsteroidal Anti-inflammatory Drug [EPC] 4 0.0000
62 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
63 Tumor Necrosis Factor Blocker [EPC] 3 0.0000
64 Vitamin C [EPC] 1 0.0000
65 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000